81 Products from 5 Active Ingredient Categories Receive Revised Market Specifications

Published: 2005-02-15 06:57:00
Updated: 2005-02-15 06:57:00
The Korea Food and Drug Administration (KFDA) recently announced that a total of 81 pharmaceutical products from 5 active ingredient categories have been issued the revised post-marketing approval specifications.

The items subject to the KFDA's revised specifications are 25 products of ciprofl...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.